Thérapie par cellules souches: A Hope for Stage 5 Maladie rénale chronique
Maladie rénale chronique (CKD) is a debilitating condition that affects millions of people worldwide. In its advanced stage, known as Stage 5 CKD, the kidneys lose their ability to function effectively, leading to a buildup of waste products in the blood and potentially life-threatening complications. Conventional treatments for Stage 5 CKD include dialysis and kidney transplantation, which can be expensive, invasive, et ont une disponibilité limitée. Thérapie par cellules souches offers a promising alternative, providing hope for patients with this devastating disease.
Understanding Stage 5 Maladie rénale chronique
Scène 5 CKD occurs when the kidneys have lost 85% or more of their function. The kidneys play a crucial role in filtering waste products from the blood, regulating blood pressure, and producing essential hormones. In Stage 5 CKD, these functions are severely impaired, leading to a buildup of toxins, fluid retention, and electrolyte imbalances. Patients with Stage 5 CKD require dialysis or kidney transplantation to survive.
Le rôle des cellules souches dans la régénération rénale
Les cellules souches sont des cellules indifférenciées qui ont le potentiel de se développer en différents types de cellules spécialisées. Dans le contexte de CKD, Les cellules souches offrent la possibilité de régénérer les tissus rénaux endommagés et de restaurer la fonction rénale. Thérapie par cellules souches involves harvesting stem cells from the patient’s own body or from a donor, then transplanting them into the kidneys. Once transplanted, the stem cells have the potential to differentiate into new kidney cells, repairing damaged tissue and improving kidney function.